Showing 1301-1310 of 8822 results for "".
Exploring Interactions Between the Pharmaceutical Industry and Dermatology Offices
https://practicaldermatology.com/topics/practice-management/exploring-interactions-between-the-pharmaceutical-industry-and-dermatology-offices/23239/There can be benefits to interaction with industry, but it’s essential to be aware of potential pitfalls.Up In Smoke? Exploring the use of CBD Oil in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/up-in-smoke-exploring-the-use-of-cbd-oil-in-dermatology/23238/What, if anything, do we know about uber-popular CBD products?The Road Map to Success: When Does it Make Sense to Have a Dermatology PA?
https://practicaldermatology.com/topics/practice-management/the-road-map-to-success-when-does-it-make-sense-to-have-a-dermatology-pa/23235/Adding a new provider can increase access and boost the bottom line. But how do you choose?Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Dermatologic Disparities: Essential Considerations in Patient Care
https://practicaldermatology.com/topics/skin-of-color/dermatologic-disparities-essential-considerations-in-patient-care/22987/A brief review of dermatologic healthcare disparities in the lesbian, gay, bisexual, and transgender (LGBT) community and racial minority groups, including African Americans, Hispanics, and Asian/Pacific Islanders.Get to Know DataDerm
https://practicaldermatology.com/topics/practice-management/get-to-know-dataderm/22067/Practical Dermatology® gets the inside scoop on the AAD's data registry from Marta Van Beek, MD.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Physician Spotlight: Vikash Oza, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vikash-oza-md/20358/Access to newer medications remains a challenge in pediatric dermatology patients.Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-r-feldman-md-phd/20541/The new thinking on improving adherence in dermatology.Guide to Surviving Consolidation
https://practicaldermatology.com/topics/practice-management/guide-to-surviving-consolidation/20874/A physician coach offers practical advice for dermatologists facing consolidation.